We advised the former shareholders of Quantib, including Holland Capital, InnovationQuarter and Erasmus Medical Centre, in the sale of shares in Quantib to RadNet, Inc. (NASDAQ: RDNT), a US leader in providing high-quality diagnostic imaging services through a network of 350 owned and operated outpatient imaging centers. Quantib is a leading radiology artificial intelligence (“AI”) company focusing on clinical solutions for prostate cancer, breast cancer and neurodegeneration.
Standard Investment sold Synres (producer of synthetic resins for coatings/paints) to the Italian chemical group COIM. In 2015, Standard Investment together with management acquired Synres from DSM. In six years, volumes have grown by more than 60% and an extensive transformation program has been implemented. COIM is an international producer of speciality chemicals with head office in Milan, Italy. The acquisition is aimed on one hand at enhancing the existing production and expertise of Synres in the field of resins and, on the other hand, at creating added value for both shareholders and employees. Olym acted for Standard Investment in this transaction.
Neerlands Glorie Groente & Fruit BV, parent company of vegetable manufacturer HAK and HAK Fresh, has acquired all shares of Four Seasons Food. The latter company (40 employees, turnover €10M/year) was founded in 2008 and is specialized in the development and production of soups, sauces and meal solutions in stand-up pouch packaging, largely based on vegetables and pulses. We advised the sellers in this transaction.
LeydenJar Technologies, a Dutch start-up originating from TNO that has developed battery technology based on 100% silicon anodes, has raised € 22 million in a new financing round for further development and upscaling. The capital was provided by a consortium of investors consisting of YARD ENERGY, Catalus Capital, Invest-NL, ING Sustainable Investments and Somerset Capital Partners together with a number of existing shareholders (including BOM, DOEN participaties and PVS Investments). We advised lead investor YARD ENERGY and the consortium of investors.
Visualfabriq has partnered with leading growth equity investment firm PSG. Visualfabriq’s SaaS platform supports global consumer packaged goods (CPG) manufacturers in managing and optimizing their promotions and demand planning. Its solutions are designed to improve revenue growth management for the world’s leading CPG brands by integrating big data, AI and intuitive workflows. PSG is a leading growth equity firm that focuses on partnering with mid-market software and technology-enabled services companies. PSG’s investment aims to accelerate Visualfabriq’s organic growth and assist in future product development. We advised Visualfabriq and its shareholders on this transaction.
Betty Blocks, a leading enterprise no-code application development platform for citizen development, has raised $33 million in funding. The round was led by European Private Equity and Venture Capital investor SmartFin Capital. Also participating were existing investors Morse Investments and NIBC Bank. We advised Betty Blocks.
Energyworx, a market leader in cloud-based Energy Data Management (EDM) solutions, announced a strategic investment of €5.1M euros by Eneco Ventures. Based in the United States and the Netherlands, Energyworx enables leading U.S. and European energy companies to unlock valuable insights in their massive granular supply, demand and contextual energy data sets. Eneco was joined in the latest round of funding by existing Energyworx investors, SET Ventures, ENGIE New Ventures and EDP Ventures — all leading investors in smart energy solutions.
We advised fintech scale-up company LendXS on the investment by IDH Farmfit Fund, whereby the latter acquired a 21% ownership stake in LendXS. LendXS develops a digital credit services platform and focuses on supporting rural financial institutions with low-cost, high-impact digital process and risk solutions.
Dutch scale-up Orderchamp, the fast-growing wholesale marketplace for brands and retailers, has raised $20 million in growth capital for further expansion in Europe. The Series-A round is led by Prime Ventures. Existing investors henQ and a number of business angels also participate in the round. We advised Prime Ventures.
We advised Enzyre on its strategic partnership with Takeda whereby Takeda invested in Enzyre. Enzyre develops ground breaking ambulant diagnostic technology focused on blood coagulation.